In the News

Keep up to date with the latest news articles from around the world.

Articles represent the views of their authors and not ME/CFS SA. Always seek advice from a registered health practitioner before changing your care plan.

05 February, 2024

Brain Changes Behind Pain Sensitivity May Affect Older Women More

A new study has found that the brain system enabling us to inhibit our own pain changes with age, and that gender-based differences in those changes may lead females to be more sensitive to moderate pain than males as older adults.

05 February, 2024

Multi Radiance Medical Breaks New Ground In Fibromyalgia Pain Relief With The First FDA-Cleared Therapeutic Laser

SOLON, Ohio--(BUSINESS WIRE)--Pioneering the frontier of super-pulsed laser technology, Multi Radiance Medical highlights the impact of FibroLux Therapeutic Laser, one of the first and only FDA-cleared therapeutic lasers designed to alleviate pain specifically for individuals battling Fibromyalgia Syndrome. Cleared by the FDA in September 2022 and officially launched late 2023, FibroLux represents a significant milestone in addressing the challenges of Fibromyalgia.

04 February, 2024

UMass Chan Advances Research Into Long COVID, Myalgic Encephalomyelitis

A study led by UMass Chan Medical School viral immunologists Liisa Selin, MD, PhD, and Anna Gil, PhD, discovered similarities in immune system dysfunction as a potential biomarker among people living with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The research also introduced a novel treatment and a method to track effective treatment interventions. The research was published online in Brain, Behavior & Immunity Health.

04 February, 2024

Blood Test Can Now Differentiate Long COVID From Fibromyalgia: Insights From University of Texas And Ohio State Studies

Understanding the overlap between fibromyalgia, known for widespread pain, and long COVID, where symptoms linger post-infection, is essential. Recent studies from the University of Texas at Austin and Ohio State University offer significant insights into these distinct yet similar conditions.

04 February, 2024

Living With Long COVID And Myalgic Encephalomyelitis

About 20% of people who have recovered from COVID-19 experience circulatory impairment, abnormal ventilatory pattern, or Myalgic encephalomyelitis (ME/CFS) according to a 2021 study published in the Journal of the American College of Cardiology. As the pandemic rages on, Ali Muldrow welcomes Eris Eady on the show. Eris has been living with Long COVID since the summer of 2020 and speaks to their experience living with the chronic illness and the challenges they faced during pregnancy.

03 February, 2024

'The Dragon's Den Debacle Shows We Urgently Need More Research Into ME/CFS'

One writer, who has witnessed the ravages of the condition up close, makes the case.

03 February, 2024

New Hope For Fibromyalgia Patients? Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval

Tonix Pharmaceuticals may have a potential new weapon against fibromyalgia for the four million adults in America that the CDC estimates are suffering from its debilitating effects. It has to do with sleep quality, not sleep quantity. Tonix’s candidate drug TNX-102 SL, which just completed its second successful phase 3 clinical trial, targets poor sleep quality – not sleep quantity – as the key mechanism to improve the daily lives of people afflicted with fibromyalgia.

03 February, 2024

Research Alert: Two New Studies By UT Experts Unveil Key Insights Into Long COVID

Approximately 10% of those infected by COVID-19 may suffer from Long COVID, say researchers.

02 February, 2024

Addressing Unmet Needs In Fibromyalgia Care, With Lora Black, PhD

Lora Black, PhD, sheds light on the importance of patient-centered education and comprehensive care in fibromyalgia.

02 February, 2024

Tracking What Changes In Our Body With Long Covid

An international team of scientists has found distinct changes in the blood of people with long Covid, suggesting a potential strategy to diagnose and perhaps treat a mysterious condition that takes many forms.

Sort By

Search Articles